0000000000635278

AUTHOR

Alberto Malesci

showing 5 related works from this author

Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine

1996

There is much experimental work on the occurrence of tolerance to the antisecretory effect of H2-receptor antagonists in healthy subjects, while data on its development in patients with duodenal ulcer are poor and conflicting. Moreover, this phenomenon has not been studied previously with 24 h gastric pH-metry in patients with active duodenal ulcer. For these reasons, we carried out a prospective pharmacodynamic investigation in 48 patients with endoscopically proven duodenal ulcer using the well-established once daily dosing schedule of H2 blockers. They were studied by means of 24 h continuous endoluminal pH-metry which was performed before, on d1 and d28 after receiving an oral bedtime d…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRanitidineBedtimeGastroenterologyH2 antagonistRanitidinePiperidinesHistamine H2 receptorOral administrationDrug toleranceInternal medicinemedicineHumansSingle-Blind MethodPharmacology (medical)Prospective StudiesPharmacologyAnalysis of Variancebusiness.industryDrug ToleranceGastric Acidity DeterminationHydrogen-Ion ConcentrationMiddle Agedmedicine.anatomical_structureHistamine H2 AntagonistsDuodenal UlcerPharmacodynamicsDuodenumFemalebusinessmedicine.drugFundamental & Clinical Pharmacology
researchProduct

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a…

2008

medicine.medical_specialtyCrohn's diseasetherapybusiness.industryGastroenterologyCompassionate Usemedicine.diseaseCertolizumabInfliximabClinical trialPharmacotherapyRefractoryCertolizumab Crohn's disease RefractoryInternal medicinemedicineImmunology and AllergyCertolizumab pegolbusinessmedicine.drug
researchProduct

Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer

1998

Background It is now clear that the extent to which gastric acid secretion must be suppressed varies with the clinical condition being treated. Aim To assess the 24-h control of gastric acidity and the individual response variability of three different doses of pantoprazole. Methods Sixty-four duodenal ulcer patients were recruited for this prospective, randomized, multicentre, double-blind, parallel-group study. They were subdivided into three well-matched groups treated with 20 mg o.m., 40 mg o.m. and 40 mg b.d. of pantoprazole, respectively. Endoscopy and intragastric pH monitoring were performed in each patient before and after 14 days of treatment. Results Fifty-five patients were elig…

Gastric Acidity Determinationmedicine.medical_specialtyChemotherapyHepatologyDosebusiness.industrymedicine.drug_classStomachmedicine.medical_treatmentGastroenterologyProton-pump inhibitorGastroenterologymedicine.anatomical_structurePharmacodynamicsInternal medicinemedicineGastric acidPharmacology (medical)businessPantoprazolemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Nutritional parameters associated with prognosis in non-critically ill hospitalized covid-19 patients: the nutri-covid19 study

2021

Background & aims: To investigate the association between the parameters used in nutritional screening assessment (body mass index [BMI], unintentional weight loss [WL] and reduced food intake) and clinical outcomes in non-critically ill, hospitalized coronavirus disease 2019 (COVID-19) patients. Methods: This was a prospective multicenter real-life study carried out during the first pandemic wave in 11 Italian Hospitals. In total, 1391 patients were included. The primary end-point was a composite of in-hospital mortality or admission to ICU, whichever came first. The key secondary end-point was in-hospital mortality. Results: Multivariable models were based on 1183 patients with comple…

Poor prognosisFood intake2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Endocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Nutritional riskNutritional StatusESPEN Best AbstractsCritical Care and Intensive Care MedicineWeight lossFood intakeInternal medicineHumansMedicineProspective StudiesObesityObesity.MortalityIntensive care medicineNutrition and DieteticsCoronavirus disease 2019business.industryCritically illMalnutritionCOVID-19Prognosismedicine.diseaseObesityHospitalizationMalnutritionNutrition Assessmentmedicine.symptombusinessBody mass indexClinical Nutrition Espen
researchProduct

Time pattern of gastric acidity in Barrett's esophagus.

1996

Increased gastroesophageal acid reflux is frequently found in patients with Barrett's esophagus, and it has been hypothesized that gastric acid hypersecretion could be an important factor aggravating the exposure of esophageal mucosa to acid and then contributing to the development of this disorder. The aim of the present study was to assess whether the circadian pattern of gastric acidity differs between refluxer patients with and without Barrett's esophagus and normal subjects. Continuous 24-hr gastric pH monitoring was performed in 119 healthy volunteers, 20 patients with Barrett's esophagus, 37 patients with moderate and 10 patients with severe reflux esophagitis without Barrett's esoph…

Malemedicine.medical_specialtyPhysiologyPopulationGastroenterologyGastric AcidBarrett EsophagusInternal medicinemedicineHumansEsophagusReflux esophagitiseducationEsophagitis PepticMonitoring Physiologiceducation.field_of_studybusiness.industryEsophageal diseaseStomachdigestive oral and skin physiologyGastroenterologyRefluxGastric Acidity DeterminationMiddle Agedmedicine.diseasedigestive system diseasesCircadian Rhythmmedicine.anatomical_structureBarrett's esophagusGastric acidFemalebusinessDigestive diseases and sciences
researchProduct